Raw-Powder Sourcing & the International Supply Chain
How AAS, SARM, and peptide raws move from bulk manufacturers to finished gray-market product
Evidence grade 4 of 5, Strong. Read how the Atlas grades evidence.
The written rationale for this grade is still being prepared.
- FDA
- Not applicable (illicit import/diversion of bulk active pharmaceutical ingredient)
Reference only. Not medical advice.
What can go wrong
The documented consequences are exposure to an unknown or substituted compound, unpredictable potency, and possible chemical or microbial contamination introduced upstream and never removed downstream. Because bulk powder is a commodity with no consumer-facing chain of custody, there is no reliable way for an end user to know what they actually received.
This is something to take to a clinician. The Atlas can tell you what is known about raw-powder sourcing & the international supply chain in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.
Behind almost every UGL vial, gray-market SARM bottle, and 'research peptide' is bulk active ingredient produced by overseas chemical manufacturers and shipped internationally. DEA investigators during Operation Raw Deal stated that essentially all US underground-steroid raw material at the time traced to Chinese factories, identifying dozens of source facilities; the earlier Operation Gear Grinder (2005) had disrupted Mexican finishing labs supplied by the same upstream chemistry. This entry documents the structure and its consequences, purity uncertainty, identity substitution, and cross-contamination, without providing any sourcing or importation detail.
The vial is finished locally, but the powder inside crossed an ocean first.
What people take it for
What it is taken for. Approval, where it exists, covers only some of these.
How it works
The finished-product seller and the end consumer sit at the bottom of a chain whose quality is decided at the top. Raw powder is produced at industrial scale, sold by the kilogram, and may be of research grade, may be a mislabeled or substituted compound, and may carry solvent residues or cross-contamination from shared equipment. Once it is dissolved and re-labeled downstream, none of this is visible to the buyer.
Why identity substitution starts upstream
When a downstream test finds a vial labeled as one hormone but containing another, the substitution frequently originated in the raw powder itself, a cheaper or more-available compound shipped in place of the ordered one. The finisher may not even know. This is why label claims on gray-market anabolic and SARM products are structurally unreliable: the error can be baked in before the finisher ever opens the bag.
Safety in detail
- Compound identity/purity is set upstream and invisible downstream
- Substitution of a cheaper compound is documented in testing
- Solvent residue and cross-contamination possible from shared equipment
- No consumer-facing chain of custody
What people get wrong
Often said'HPLC certificate from the source proves purity'
ActuallyA certificate of analysis supplied by the seller is only as trustworthy as the seller; independent third-party testing of the actual received material is the only meaningful check.
Often said'Peptide raws are cleaner than steroid raws'
ActuallyAll gray-market raws share the same core problem: purity and identity are decided upstream, unverified, and can include truncated or mis-synthesized product for peptides.
Who profits, and who pushes back
Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.
What we do not know
- How much modern gray-market raw material still originates from a small number of overseas facilities versus a diversified supply?
- How often is downstream compound substitution introduced at the raw-powder stage versus the finishing stage?
The market for this
What follows describes how this is bought and sold. It is not a buying guide and it is not an endorsement of any seller.
Bulk manufactureOverseas industrial-scale API/chemical producersInternational shipmentKilogram-quantity raw powder crosses bordersLocal finishingDissolved, pressed, or reconstituted and re-labeled by UGL/vendorRetailGyms, web stores, encrypted chat
At a glance
- Upstream
- Overseas bulk chemical / API manufacturers
- DEA finding (2007)
- Investigators cited China as the origin of the overwhelming majority of US steroid raws
- Predecessor case
- Operation Gear Grinder (2005), Mexican finishing labs
- Consumer risk
- Powder identity/purity set upstream, invisible to buyer
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about Raw-Powder Sourcing & the International Supply Chain. A short entry is not a safe entry.
- Timeline. We have not built the dated record of research and regulatory events.
- Cost and market. We have not documented what it sells for or who sells it.
- Who uses it. We have not documented the user groups.
- What could change. No forward-looking summary yet.
- How it compares. We have not set it against the alternatives.
- Children and teenagers. We have not checked what is known about younger people.
Sources
The studies below are named and described, but not linked. You cannot open them from here and check our reading against them, which means this page is our summary of the literature rather than a document you can verify. Weigh it accordingly until the links exist.
The studies that matter
DEA Operation Raw Deal briefing2007
Investigators attributed the overwhelming majority of US steroid raw material to Chinese-origin factories
Operation Gear Grinder2005
Disrupted Mexican finishing labs fed by the same upstream chemistry